Last reviewed · How we verify

NCT05554861

Effects of Repetitive Transcranial Magnetic Stimulation Therapy on Lower Extremity Motor Development in Stroke Patients

Completed NA Last updated 14 November 2023
What this trial tests

NA trial testing Low Frequency rTMS Protocol in Neurological Rehabilitation in 60 participants. Completed in 13 November 2023.

Timeline
20 September 2022
Primary endpoint
20 September 2023
13 November 2023

Quick facts

Lead sponsorAfyonkarahisar Health Sciences University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment60
Start date20 September 2022
Primary completion20 September 2023
Estimated completion13 November 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Afyonkarahisar Health Sciences University

Who can join

Adults 50 to 80, any sex, with Neurological Rehabilitation or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to investigate the effects of rTMS applications at different current frequencies (low frequency / intermittent (intermittent) theta burst (iTBS)) in stroke patients on lower extremity motor development, physical function and quality of life, and to compare the effectiveness of these modalities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Low Frequency rTMS Protocol

Trials testing the same drug.

Other recruiting trials for Neurological Rehabilitation

Currently open trials in the same condition.

Other Afyonkarahisar Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05554861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing